Clinical Trials Sponsored by Vergent Bioscience, Inc.

Total 827 results

American Regent, Inc.

Unknown

Trial to Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron and to Compare Safety, Effect on Quality of Life, and Resource Utilization of Injectafer vs Intravenous Standard of Care for the Treatment of IDA in an Infusion Center Setting

Iron Deficiency Anemia (IDA)
American Regent, Inc.

Terminated

Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopath

Calciphylaxis | Calcific Uremic Arteriolopathy

United States
American Regent, Inc.

Completed

Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine (IN) for Postoperative Pain

Postoperative Pain

New Zealand
American Regent, Inc.

Completed

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Safety and Efficacy of Iron Sucrose in Children

Anemia | Chronic Kidney Disease

United States
American Regent, Inc.

Completed

Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

Anemia
American Regent, Inc.

Completed

Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)

Restless Legs Syndrome (RLS)
American Regent, Inc.

Completed

Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients

Anemia

United States
American Regent, Inc.

Completed

Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments

Restless Legs Syndrome
American Regent, Inc.

Completed

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia

Anemia

United States
American Regent, Inc.

Withdrawn

Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum) (ASSURED)

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Taxoprexin® Treatment for Advanced Eye Melanoma

Metastatic Melanoma

United States
American Regent, Inc.

Completed

Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures

Pain

United States
American Regent, Inc.

Completed

Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia

Anemia

United States
American Regent, Inc.

Not yet recruiting

Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition

Manganese Safety in Adults
American Regent, Inc.

Withdrawn

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

Iron Deficiency, Anaemia

United States
American Regent, Inc.

Terminated

Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia

Restless Legs Syndrome (RLS)

United States
American Regent, Inc.

Completed

A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA

Iron Deficiency Anemia (IDA)

Poland, Russian Federation
American Regent, Inc.

Completed

Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis

Anemia
American Regent, Inc.

Completed

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer® (IRON CLAD)

Cancer and Chemotherapy Related Anemia

United States
American Regent, Inc.

Completed

Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass

Iron Deficiency Anemia Secondary to IBD or Gastric Bypass
American Regent, Inc.

Completed

Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease

Chronic Kidney Disease

United States
American Regent, Inc.

Completed

Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

Anemia

United States
American Regent, Inc.

Completed

Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Anemia

United States
American Regent, Inc.

Completed

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

Anemia

United States
American Regent, Inc.

Completed

Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia

Fibromyalgia | Iron Deficiency

United States
American Regent, Inc.

Completed

Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function (REPAIR-IDA)

Iron Deficiency Anemia | Impaired Renal Function

United States
American Regent, Inc.

Completed

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia

Anemia

United States
American Regent, Inc.

Completed

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

Anemia

United States
American Regent, Inc.

Completed

Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults

Methemoglobinemia | Congenital Methemoglobinemia
American Regent, Inc.

Completed

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

Malignant Melanoma

United States
American Regent, Inc.

Completed

Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia

Myelofibrosis | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome

United States
American Regent, Inc.

Completed

Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia

Iron Deficiency Anemia (IDA)

United States
American Regent, Inc.

Terminated

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver

Cancer of the Liver

United States
American Regent, Inc.

Completed

Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects

Healthy Subjects

United States
Shanghai Junshi Bioscience Co., Ltd.
CTI Clinical Trial and Consulting Services; TopAlliance Biosciences, Inc.

Withdrawn

A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

Malignancies | Previously Treated, Advanced
Meridian Bioscience, Inc.
Conatus Pharmaceuticals

Completed

Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14

Cirrhosis | Portal Hypertension | NASH - Nonalcoholic Steatohepatitis

France
Forest Laboratories
Cypress Bioscience, Inc.

Terminated

Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)

Primary Fibromyalgia

United States
Forest Laboratories
Cypress Bioscience, Inc.

Completed

Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia

Fibromyalgia

United States
Exelixis
Arcus Biosciences, Inc.

Recruiting

Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)

Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors

United States
Emalex Biosciences Inc.
Covance

Completed

Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects

Healthy Volunteer

United Kingdom
Coherus Biosciences, Inc.
Shire

Completed

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

Plaque Psoriasis

United States, Israel, Australia, Germany, South Africa, Poland, Canada
MBX Biosciences
ProSciento, Inc.

Recruiting

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

Postbariatric Hypoglycemia

United States
Alume Biosciences, Inc.
Ergomed

Recruiting

ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery

Surgery

United States
AstraZeneca
Arcus Biosciences, Inc.

Recruiting

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC (PACIFIC-8)

Non-Small Cell Lung Cancer

Korea, Republic of, Philippines, United States, Belgium, Hungary, India, Norway, United Kingdom, France, Canada, Germany, Japan, Malaysia, Taiwan, Greece, Italy, Mexico, Turkey, South Africa, Chile, Brazil, Romania, Spain, Switzerland, ... and more
Leonard-Meron Biosciences, Inc.

Available

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI (MLK)

Catheter-Related Infections

United States, Puerto Rico
AstraZeneca
Ardea Biosciences, Inc.

Completed

Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia

Gout and Hyperuricemia

Japan

3

Subscribe